Alembic Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 05/02/2026 ,inter alia, to consider and approve Unaudited Financial ....
APLLTD · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Alembic Pharmaceuticals has informed the stock exchanges that its Board of Directors will meet on Thursday, 5th February 2026 to consider and approve the Unaudited Financial Results for the quarter and nine months ended 31st December 2025 (Q3 FY26 and 9M FY26). The trading window for dealing in the company's securities has been closed since 1st January 2026 and will reopen 48 hours after the financial results are declared. This is a routine regulatory filing ahead of the earnings announcement.
No direct impact on the stock from this filing — it is purely a procedural intimation. Investors should watch for the actual Q3 FY26 results on 5th February 2026, which could drive near-term price movement depending on performance versus expectations.